East Penn Rheumatology Associates

Bethlehem, Pennsylvania 18015

0 studies enrolling now · 11 studies all time

What they study most

Active Psoriatic Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus

Studies at this site

• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) — Completed
• A Study of Belimumab in Subjects With Systemic Lupus Erythematosus — Completed
• Methotrexate-Inadequate Response Study — Completed
• Phase IIIB Subcutaneous Missed Dose Study — Completed
• Phase IIIB Subcutaneous Abatacept Monotherapy Study — Completed
• Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1) — Completed